Abstract
..
Main
..
RCT vs. Obs.
..
Feedback
Home
c19early.org COVID-19 treatment researchFavipiravirFavipiravir (more..)
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta
Thermotherapy Meta
Melatonin Meta
Metformin Meta
Home Adoption Other Treatments
@CovidAnalysis
Loading...
 
Analgesics⏵
Antiandrogens⏵
Antihistamines⏵
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle⏵
Melatonin
Metformin
Minerals⏵
Monoclonals⏵
Mpro inhibitors⏵
Naso/orophar..⏵
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors⏵
TMPRSS2 inh.⏵
Thermotherapy
Vitamins⏵
More⏵
 

Supplementary Data — Favipiravir for COVID-19: real-time meta analysis of 71 studies

@CovidAnalysis, May 2025, Version 82V82
PDF
All
Studies
All
Treatments
Feedback
https://c19early.org/ameta.html
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Ruzhentsova (RCT) 6% 0.94 [0.78-1.14] hosp. 3/112 2/56 Improvement, RR [CI] Treatment Control Ruzhentsova (RCT) 39% 0.61 [0.43-0.88] no recov. 112 (n) 56 (n) Ruzhentsova (RCT) 22% 0.78 [0.92-1.79] viral+ 112 (n) 56 (n) Udwadia (RCT) 66% 0.34 [0.01-8.12] death 0/73 1/75 Udwadia (RCT) 29% 0.71 [0.49-1.03] no recov. 75 (n) 72 (n) Udwadia (RCT) 43% 0.57 [0.36-0.91] no recov. 75 (n) 72 (n) Udwadia (RCT) 27% 0.73 [0.51-1.06] viral time 75 (n) 72 (n) Sawanpanyalert 68% 0.32 [0.15-0.66] progression n/a n/a Holubar (DB RCT) 89% 0.11 [0.01-2.02] hosp. 0/75 4/74 Holubar (DB RCT) 30% 0.70 [0.23-2.12] ER visit 5/75 7/74 Holubar (DB RCT) -19% 1.19 [0.78-1.85] no recov. 65 (n) 70 (n) Holubar (DB RCT) -32% 1.32 [0.83-2.08] viral+ 59 (n) 57 (n) Alattar (PSM) 33% 0.67 [0.28-1.61] death 8/387 12/387 Alattar (PSM) -2% 1.02 [0.90-1.16] no recov. 26/387 28/387 Alattar (PSM) -6% 1.06 [0.99-1.14] recov. time 387 (n) 387 (n) Alattar (PSM) 44% 0.56 [0.44-0.71] viral+ 78/387 139/387 Bosaeed (DB RCT) -619% 7.19 [0.38-138] ICU 3/112 0/119 Bosaeed (DB RCT) -219% 3.19 [0.66-15.5] hosp. 6/112 2/119 Bosaeed (DB RCT) -12% 1.12 [0.80-1.56] no recov. 112 (n) 119 (n) Bosaeed (DB RCT) -15% 1.15 [0.75-1.75] viral+ 112 (n) 119 (n) FLARE Lowe (DB RCT) -202% 3.02 [0.13-72.6] ICU 1/59 0/60 FLARE Lowe (DB RCT) -202% 3.02 [0.13-72.6] hosp. 1/59 0/60 FLARE Lowe (DB RCT) 28% 0.72 [0.44-0.98] viral+ 29/54 38/52 Adhikari (RCT) -40% 1.40 [0.57-3.44] no improv. 10/38 6/32 Adhikari (RCT) -36% 1.36 [0.52-3.59] no improv. 8/27 5/23 Adhikari (RCT) -64% 1.64 [0.18-15.3] no improv. 2/11 1/9 Tsuzuki 13% 0.87 [0.52-1.46] death 2,532 (n) 5,122 (n) Tsuzuki -2% 1.02 [0.65-1.60] ventilation 2,532 (n) 5,122 (n) Tsuzuki 18% 0.82 [0.66-1.04] progression 2,532 (n) 5,122 (n) Qadir 97% 0.03 [0.00-0.47] death 0/125 17/125 Qadir 60% 0.40 [0.23-0.71] hosp. 14/125 35/125 Qadir 97% 0.03 [0.00-0.47] no recov. 0/125 17/125 Qadir 71% 0.29 [0.17-0.50] no recov. 14/125 48/125 Qadir 79% 0.21 [0.13-0.36] no recov. 14/125 66/125 Qadir 71% 0.29 [0.22-0.40] no recov. 32/125 109/125 Qadir 58% 0.42 [0.25-0.70] recov. time 125 (n) 125 (n) Usanma Koban 86% 0.14 [0.02-0.70] viral+ 47 (n) 79 (n) Sirijatuphat (RCT) 64% 0.36 [0.20-0.64] improv. 62 (n) 31 (n) Sirijatuphat (RCT) 90% 0.10 [0.03-0.39] improv. 62 (n) 31 (n) Sirijatuphat (RCT) 43% 0.57 [0.23-1.43] progression 8/62 7/31 Sirijatuphat (RCT) -4% 1.04 [0.63-1.72] viral+ 62 (n) 31 (n) McMahon (RCT) -1% 1.01 [0.34-3.03] oxygen 6/99 6/100 McMahon (RCT) -56% 1.56 [0.71-3.43] hosp. 14/99 9/99 PRESECO Golan (DB RCT) 67% 0.33 [0.01-8.12] death 0/599 1/588 PRESECO Golan (DB RCT) 2% 0.98 [0.43-2.25] progression 11/599 11/588 PRESECO Golan (DB RCT) 7% 0.93 [0.77-1.12] progression 159/599 168/588 PRESECO Golan (DB RCT) 4% 0.96 [0.71-1.29] no recov. 73/599 75/588 PRESECO Golan (DB RCT) 14% 0.86 [0.81-0.91] viral time 140 (n) 132 (n) Bruminhent -227% 3.27 [1.43-7.50] progression n/a n/a Chandiwana (RCT) -13% 1.13 [0.23-5.46] progression 37 (n) 39 (n) CT​2​ Chandiwana (RCT) -23% 1.23 [0.73-2.08] recov. time 37 (n) 39 (n) CT​2​ Chandiwana (RCT) -67% 1.67 [0.85-3.23] viral+ 27/37 25/38 CT​2​ Vaezi (DB RCT) -105% 2.05 [0.40-10.6] hosp. 4/38 2/39 PLATCOV Luvira (RCT) -6% 1.06 [0.93-1.21] viral rate 116 (n) 132 (n) Lokanuwatsatien 14% 0.86 [0.64-1.17] PASC 400 (n) 402 (n) Iwata (DB RCT) -16% 1.16 [0.45-2.21] oxygen 12/43 12/43 Iwata (DB RCT) 19% 0.81 [0.17-2.28] oxygen 5/24 6/22 Iwata (DB RCT) -16% 1.16 [0.74-1.82] viral+ 21/41 19/43 Iwata (DB RCT) 6% 0.94 [0.69-1.28] viral+ 26/41 29/43 Iwata (DB RCT) 1% 0.99 [0.82-1.20] viral+ 34/41 36/43 Iwata (DB RCT) 6% 0.94 [0.82-1.09] viral+ 36/41 40/43 FaviPrev Siripongboonsitti 25% 0.75 [0.51-0.97] transmission 1,064/1,836 122/170 Cai 69% 0.31 [0.10-0.96] pneumonia 35 (n) 45 (n) Cai 71% 0.29 [0.10-0.86] viral+ 35 (n) 45 (n) Ivashchenko (RCT) -300% 4.00 [0.20-79.6] death 2/40 0/20 Ivashchenko (RCT) -300% 4.00 [0.20-79.6] ventilation 2/40 0/20 Ivashchenko (RCT) -300% 4.00 [0.20-79.6] ICU 2/40 0/20 Ivashchenko (RCT) 46% 0.54 [0.33-0.88] viral+ 15/40 14/20 Ivashchenko (RCT) 62% 0.38 [0.09-1.52] viral+ 3/40 4/20 Ivashchenko (RCT) -67% 1.67 [0.52-5.39] no disch. 10/40 3/20 Lou (RCT) -422% 5.22 [0.28-96.2] ICU 2/9 0/10 Lou (RCT) 11% 0.89 [0.34-2.32] no recov. 4/9 5/10 Lou (RCT) 14% 0.86 [0.58-1.30] no recov. 7/9 9/10 Lou (RCT) -422% 5.22 [0.28-96.2] viral+ 2/9 0/10 Lou (RCT) -11% 1.11 [0.47-2.60] viral+ 5/9 5/10 Pushkar (RCT) 14% 0.86 [0.73-1.00] no recov. 73/100 85/100 Pushkar (RCT) 33% 0.67 [0.54-0.82] recov. time 100 (n) 100 (n) Pushkar (RCT) 45% 0.55 [0.42-0.72] no recov. 40/100 73/100 Pushkar (RCT) 20% 0.80 [0.64-1.00] recov. time 100 (n) 100 (n) Pushkar (RCT) 70% 0.30 [0.16-0.58] no disch. 10/100 33/100 Pushkar (RCT) 27% 0.73 [0.63-0.86] no recov. 66/100 90/100 Pushkar (RCT) 33% 0.67 [0.50-0.89] pneumonia 40/100 60/100 Pushkar (RCT) 90% 0.10 [0.02-0.40] viral+ 2/100 21/100 Khamis (RCT) 15% 0.85 [0.28-2.59] death 5/44 6/45 OT​1​ CT​2​ Khamis (RCT) -2% 1.02 [0.42-2.48] ICU 8/44 8/45 OT​1​ CT​2​ Khamis (RCT) -10% 1.10 [0.60-1.99] no recov. 15/44 14/45 OT​1​ CT​2​ Solaymani.. (RCT) -19% 1.19 [0.70-2.04] death 26/190 21/183 OT​1​ Solaymani.. (RCT) -53% 1.53 [0.86-2.71] ventilation 27/190 17/183 OT​1​ Solaymani.. (RCT) -19% 1.19 [0.73-1.94] ICU 31/190 25/183 OT​1​ Zhao (RCT) 59% 0.41 [0.16-1.03] viral+ 7/36 9/19 Zhao (RCT) 52% 0.48 [0.25-0.91] viral time 36 (n) 19 (n) Haji Aghajani 26% 0.74 [0.43-1.27] death 40 (n) 951 (n) Alamer -56% 1.56 [0.73-3.36] death 12/233 21/223 Alamer 90% 0.10 [0.04-0.29] ventilation 4/218 27/165 Alamer 49% 0.51 [0.41-0.64] no disch. 221 (n) 201 (n) Almoosa -42% 1.42 [0.90-2.25] death 33/110 24/116 Almoosa -149% 2.49 [1.29-4.80] death 26/110 11/116 Almoosa 62% 0.38 [0.13-1.17] death 4/110 11/116 Almoosa -90% 1.90 [1.11-3.26] ICU 110 (n) 116 (n) Almoosa -11% 1.11 [0.96-1.29] recov. time 110 (n) 116 (n) Shinkai (SB RCT) 37% 0.63 [0.40-0.98] imp. time 107 (n) 49 (n) Shinkai (SB RCT) 59% 0.41 [0.18-0.93] imp. time 47 (n) 13 (n) Assiri (ICU) -79% 1.79 [0.33-8.02] death 11/67 3/51 ICU patients Kulzhanova 88% 0.12 [0.04-0.37] no improv. 3/40 25/40 Kulzhanova 89% 0.11 [0.01-2.00] no improv. 0/40 4/40 Kulzhanova 50% 0.50 [0.21-1.20] viral+ 6/40 12/40 Chen (RCT) -3% 1.03 [0.15-7.22] ICU 2/116 2/120 OT​1​ Chen (RCT) 74% 0.26 [0.03-2.28] resp. failure 1/116 4/120 OT​1​ Chen (RCT) 20% 0.80 [0.48-1.34] oxygen 21/116 27/120 OT​1​ Chen (RCT) 70% 0.30 [0.10-0.87] dyspnea 4/116 14/120 OT​1​ Chen (RCT) 10% 0.90 [0.45-1.80] dyspnea 13/116 15/120 OT​1​ Chen (RCT) 20% 0.80 [0.60-1.08] no recov. 45/116 58/120 OT​1​ Alotaibi 57% 0.43 [0.18-1.01] death 244 (n) 193 (n) OT​1​ Tabarsi (RCT) 30% 0.70 [0.17-2.88] death 3/32 4/30 OT​1​ Tabarsi (RCT) 41% 0.59 [0.22-1.59] ICU 5/32 8/30 OT​1​ Tabarsi (RCT) 6% 0.94 [0.72-1.23] CT imp. 24/32 24/30 OT​1​ Tabarsi (RCT) 25% 0.75 [0.58-0.97] hosp. time 32 (n) 30 (n) OT​1​ FIGHT-COVID-19 Atipornwa.. (RCT) 23% 0.77 [0.35-1.67] death 10/100 13/100 OT​1​ CT​2​ FIGHT-COVID-19 Atipornwa.. (RCT) 60% 0.40 [0.20-0.79] progression 10/100 25/100 OT​1​ CT​2​ FIGHT-COVID-19 Atipornwa.. (RCT) 9% 0.91 [0.73-1.14] viral time 50 (n) 50 (n) OT​1​ CT​2​ FIGHT-COVID-19 Atipornwa.. (RCT) 9% 0.91 [0.75-1.10] viral time 50 (n) 50 (n) OT​1​ CT​2​ Damayanti 54% 0.46 [0.22-0.92] no recov. 96 (n) 96 (n) Shenoy (DB RCT) -29% 1.29 [0.60-2.77] death 14/175 11/178 Shenoy (DB RCT) -33% 1.33 [0.67-2.66] ventilation 17/175 13/178 Shenoy (DB RCT) -2% 1.02 [0.57-1.82] ICU 20/175 20/178 Shenoy (DB RCT) -1% 1.01 [0.78-1.30] no recov. 157 (n) 158 (n) Shenoy (DB RCT) 6% 0.94 [0.75-1.18] no recov. 175 (n) 178 (n) Shenoy (DB RCT) 17% 0.83 [0.58-1.18] no recov. 157 (n) 158 (n) Shenoy (DB RCT) 32% 0.68 [0.50-0.93] no recov. 175 (n) 178 (n) Chuah (RCT) -1154% 12.54 [0.76-208] death 5/250 0/250 Chuah (RCT) -20% 1.20 [0.36-3.97] ventilation 6/250 5/250 Chuah (RCT) -9% 1.09 [0.49-2.31] ICU 13/250 12/250 Finberg (RCT) -200% 3.00 [0.13-70.3] death 1/25 0/25 Finberg (RCT) -200% 3.00 [0.13-70.3] ventilation 1/25 0/25 Finberg (RCT) 58% 0.42 [0.16-1.10] no recov. 25 (n) 25 (n) Finberg (RCT) -46% 1.46 [0.45-4.81] no recov. 25 (n) 25 (n) Finberg (RCT) 47% 0.53 [0.29-0.98] viral time 25 (n) 25 (n) Al Mutair (ICU) 7% 0.93 [0.77-1.12] death 119/269 128/269 ICU patients OT​1​ Al Mutair (ICU) -9% 1.09 [0.82-1.43] ARDS 76/269 70/269 ICU patients OT​1​ Al Mutair (ICU) -34% 1.34 [1.13-1.59] ICU 269 (n) 269 (n) ICU patients OT​1​ Al Mutair (ICU) -37% 1.37 [1.14-1.64] hosp. time 269 (n) 269 (n) ICU patients OT​1​ Kurniyanto 48% 0.52 [0.22-1.25] death 10/325 9/152 Cilli 38% 0.62 [0.24-1.63] death 5/23 8/23 Al-Muhsen -263% 3.63 [1.06-12.4] death 156 (n) 442 (n) Al-Muhsen 41% 0.59 [0.47-0.75] oxygen 52/156 248/442 Al-Muhsen -40% 1.40 [1.03-1.91] hosp. time 156 (n) 442 (n) Yulia 85% 0.15 [0.02-1.02] death 432 (all patients) Uyaroğlu (PSM) 67% 0.33 [0.01-7.96] death 0/42 1/42 OT​1​ Uyaroğlu (PSM) -200% 3.00 [0.13-71.6] ICU 1/42 0/42 OT​1​ Uyaroğlu (PSM) -11% 1.11 [0.24-5.08] hosp. time 42 (n) 42 (n) OT​1​ AlQahtani (RCT) -196% 2.96 [0.12-71.1] death 1/54 0/52 AlQahtani (RCT) 76% 0.24 [0.03-2.08] ICU 1/54 4/52 AlQahtani (RCT) -42% 1.42 [0.50-4.04] no recov. 8/53 5/47 AlQahtani (RCT) 43% 0.57 [0.27-1.21] viral+ 8/40 14/40 Shinada 7% 0.93 [0.45-1.89] hosp. 17 (n) 17 (n) Shinada 55% 0.45 [0.21-0.96] viral+ 17 (n) 17 (n) Hassaniazad (RCT) 68% 0.32 [0.07-1.48] death 2/32 6/31 OT​1​ Hassaniazad (RCT) 3% 0.97 [0.06-14.8] death 1/32 1/31 OT​1​ Hassaniazad (RCT) 35% 0.65 [0.20-2.07] ICU 4/32 6/31 OT​1​ Hassaniazad (RCT) 25% 0.75 [0.51-1.10] hosp. time 32 (n) 31 (n) OT​1​ Hassaniazad (RCT) 18% 0.82 [0.62-1.08] viral+ 22/32 26/31 OT​1​ Hafez -3% 1.03 [0.68-1.56] viral+ 59 (n) 1,446 (n) CT​2​ Hafez 59% 0.41 [0.15-1.15] viral+ 4 (n) 1,446 (n) CT​2​ Rahman (DB RCT) 89% 0.11 [0.01-0.75] no improv. 1/19 8/16 Rahman (DB RCT) 65% 0.35 [0.16-0.78] no improv. 5/19 12/16 Rahman (DB RCT) 47% 0.53 [0.34-0.81] no improv. 10/19 16/16 Rahman (DB RCT) 92% 0.08 [0.01-0.59] viral+ 1/25 12/25 Rahman (DB RCT) 62% 0.38 [0.18-0.80] viral+ 6/25 16/25 Rahman (DB RCT) 48% 0.52 [0.36-0.76] viral+ 13/25 25/25 Tehrani (RCT) 34% 0.66 [0.34-1.26] hosp. 10/38 16/40 Tehrani (RCT) 80% 0.20 [0.01-4.12] no recov. 0/38 2/40 Tehrani (RCT) 58% 0.42 [0.21-0.84] no recov. 8/38 20/40 Tehrani (RCT) 47% 0.53 [0.05-5.57] no recov. 1/38 2/40 Tehrani (RCT) 47% 0.53 [0.20-1.40] no recov. 5/38 10/40 Tehrani (RCT) 66% 0.34 [0.01-8.07] no recov. 0/38 1/40 Tehrani (RCT) 47% 0.53 [0.10-2.71] no recov. 2/38 4/40 Tehrani (RCT) 30% 0.70 [0.45-1.10] no recov. 16/38 24/40 Tehrani (RCT) 7% 0.93 [0.75-1.15] no recov. 30/38 34/40 Tehrani (RCT) 21% 0.79 [0.30-2.06] no recov. 6/38 8/40 Tehrani (RCT) 38% 0.62 [0.33-1.18] no recov. 10/38 17/40 Abdulrahman (ICU) 3% 0.97 [0.81-1.18] death 74/193 593/1,506 ICU patients Acar Sevinc (ICU) 16% 0.84 [0.62-1.12] death 57/85 12/15 ICU patients OT​1​ Acar Sevinc (ICU) 10% 0.90 [0.67-1.19] ventilation 61/85 12/15 ICU patients OT​1​ Tawfik 96% 0.04 [0.00-0.26] death 1/103 17/62 Tawfik 21% 0.79 [0.45-1.40] ICU 21/103 16/62 Tawfik 16% 0.84 [0.80-0.88] hosp. time 102 (n) 58 (n) Babayigit -184% 2.84 [1.27-6.14] ventilation 47/325 17/977 Babayigit -181% 2.81 [1.66-4.62] ICU 75/325 35/969 Babayigit -100% 2.00 [1.33-3.02] hosp. time 265 (n) 746 (n) Behboodikhah 68% 0.32 [0.05-1.83] death 95 (n) 2,079 (n) PIONEER Shah (RCT) 26% 0.74 [0.44-1.23] death 26/251 34/248 PIONEER Shah (RCT) 24% 0.76 [0.49-1.16] ventilation 251 (n) 248 (n) PIONEER Shah (RCT) 6% 0.94 [0.79-1.12] no recov. 251 (n) 248 (n) Alosaimi (PSM) 80% 0.20 [0.01-4.03] death 0/37 2/37 OT​1​ Alosaimi (PSM) -75% 1.75 [0.20-15.6] hosp. time 37 (n) 37 (n) OT​1​ Alosaimi (PSM) -40% 1.40 [0.21-9.26] no disch. 37 (n) 37 (n) OT​1​ Delen 23% 0.77 [0.19-3.20] ICU 3/34 4/35 Delen 88% 0.12 [0.02-0.91] no recov. 1/21 8/21 Delen -2% 1.02 [0.90-1.16] hosp. time 34 (n) 35 (n) Delen -3% 1.03 [0.88-1.21] no disch. 31/34 31/35 Hartantri 76% 0.24 [0.11-0.54] death n/a n/a Hartantri 60% 0.40 [0.17-0.98] death n/a n/a Alshamrani (PSM) -14% 1.14 [0.96-1.35] death 326/1,159 316/1,380 Alshamrani (PSM) -2% 1.02 [0.86-1.20] progression 475/1,159 499/1,380 Alshamrani (PSM) -19% 1.19 [1.05-1.34] ICU 668 (n) 633 (n) Alshamrani (PSM) -29% 1.29 [1.11-1.50] hosp. time 1,159 (n) 1,380 (n) Arfijanto 51% 0.49 [0.26-0.94] viral+ 8/37 55/125 Sulaiman (ICU) -17% 1.17 [0.73-1.87] death 73 (n) 73 (n) ICU patients Sulaiman (ICU) 14% 0.86 [0.53-1.39] death 73 (n) 73 (n) ICU patients Sulaiman (ICU) -47% 1.47 [1.11-1.95] ventilation time 73 (n) 73 (n) ICU patients Sulaiman (ICU) -50% 1.50 [1.10-2.04] ICU 73 (n) 73 (n) ICU patients Shamsi 96% 0.04 [0.00-3.01] death 0/19 24/164 FAVID Horcajada (DB RCT) -383% 4.83 [0.24-95.1] death 2/23 0/21 FAVID Horcajada (DB RCT) -37% 1.37 [0.25-7.41] ventilation 3/23 2/21 FAVID Horcajada (DB RCT) 17% 0.83 [0.40-1.74] recov. time 23 (n) 21 (n) FAVID Horcajada (DB RCT) -125% 2.25 [0.21-23.7] viral time 23 (n) 21 (n) Alsaraj (RCT) -87% 1.87 [0.67-5.21] death 9/51 5/53 Saito -168% 2.68 [0.96-7.48] death 7/40 6/92 PRINCIPLE Hobbs (RCT) 86% 0.14 [0.01-2.65] death 0/1,829 3/1,668 PRINCIPLE Hobbs (RCT) -191% 2.91 [0.12-71.4] ICU 1/1,825 0/1,663 PRINCIPLE Hobbs (RCT) 1% 0.99 [0.61-1.61] death/hosp. 1,829 (n) 3,256 (n) PRINCIPLE Hobbs (RCT) 17% 0.83 [0.73-0.94] no recov. 350/1,582 378/1,412 PRINCIPLE Hobbs (RCT) 12% 0.88 [0.78-0.99] no recov. 378/1,503 384/1,340 PRINCIPLE Hobbs (RCT) 17% 0.83 [0.74-0.92] no recov. 418/1,507 459/1,370 PRINCIPLE Hobbs (RCT) 29% 0.71 [0.53-0.95] no recov. 1,829 (n) 1,668 (n) PRINCIPLE Hobbs (RCT) 19% 0.81 [0.75-0.88] no recov. 1,829 (n) 3,256 (n) PRINCIPLE Hobbs (RCT) 34% 0.66 [0.58-0.75] no recov. 1,828 (n) 1,666 (n) PRINCIPLE Hobbs (RCT) 25% 0.75 [0.69-0.83] no recov. 1,829 (n) 1,668 (n) PRINCIPLE Hobbs (RCT) 12% 0.88 [0.81-0.94] no recov. 1,562 (n) 1,407 (n) PRINCIPLE Hobbs (RCT) 21% 0.79 [0.73-0.86] no recov. 1,562 (n) 1,407 (n) PRINCIPLE Hobbs (RCT) 23% 0.77 [0.72-0.83] no recov. 1,828 (n) 1,667 (n) Favipiravir COVID-19 outcomes c19early.org May 2025 ​1​ OT: comparison with other treatment​2​ CT: study uses combined treatment Favors favipiravir Favors control
Figure S1. All outcomes.
Loading..
Figure S2. Comparison of results for RCTs versus observational studies. For COVID-19 treatments, there is no significant difference between the results of RCTs and observational studies. Observational studies do not systematically over or underestimate efficacy. For high-cost treatments, there is a non-significant trend towards RCTs showing greater efficacy.
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit    
Post
Share
@CovidAnalysis
FAQ
Public domain CC0 1.0